aplastic anemia | Page 42 | Aplastic Anemia and MDS International Foundation

aplastic anemia

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus host disease after allogeneic stem cell transplantation for acquired aplastic anemia.

Author(s): 
Marsh JC, Gupta V, Lim Z, Ho AY, Ireland R, Hayden J, Potter V, Koh MB, Islam M, Russell N, Marks DI, Mufti GJ, Pagliuca A.
Primary Author: 
Marsh JC
Journal Title: 
Blood
Original Publication Date: 
Apr 2011

We evaluated a novel

Bone Marrow Diseases: 

SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

Author(s): 
Afable MG 2nd, Wlodarski M, Makishima H, Shaik M, Sekeres MA, Tiu RV, Kalaycio M, O'Keefe CL, Maciejewski JP
Primary Author: 
Afable MG 2nd
Journal Title: 
Blood
Original Publication Date: 
Apr 2011

First-line matched related donor hematopoietic stem cell transplantation compared to immunosuppressive therapy in acquired severe aplastic anemia.

Author(s): 
Peinemann F, Grouven U, Kröger N, Bartel C, Pittler MH, Lange S
Primary Author: 
Peinemann F
Journal Title: 
PLoS One.
Original Publication Date: 
Apr 2011

INTRODUCTION:

Bone Marrow Diseases: 

Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome

Author(s): 
Garg R, Faderl S, Garcia-Manero G, Cortes J, Koller C, Huang X, York S, Pierce S, Brandt M, Beran M, Borthakur G, Kantarjian H, Ravandi F
Primary Author: 
Garg R
Journal Title: 
Leukemia
Original Publication Date: 
Jul 2009

We investigated efficacy and safety of rabbit anti-thymocyte globulin (rATG),